Methods and kits for producing a fibrin matrix

Abstract

Methods for producing a fibrin matrix comprising a fusion peptide are described herein. In some embodiments, the method includes providing three different components, including a first component containing fibrinogen or a fibrinogen precursor and optionally, transglutaminase or a transglutaminase precursor, a second component containing thrombin or a thrombin precursor, and a third component containing a fusion peptide. In these embodiments, neither the first component nor the second component includes the fusion peptide. In some embodiments, the first or second components are premixed with the third component. The first, second and third components are mixed to form a fibrin matrix comprising a covalently linked fusion peptide. The mixing is carried out in a time frame of not more than 5 days. A kit for producing the fibrin matrix comprising a covalently linked fusion peptide is also described herein.

1 . A method for forming a fibrin matrix comprising a fusion peptide, wherein the method comprises the steps of:
 i) providing a first component comprising fibrinogen or a fibrinogen precursor and a transglutaminase (TG) or a transglutaminase precursor,   ii) providing a second component comprising thrombin or a thrombin precursor,   wherein neither the first component nor the second component comprises a fusion peptide comprising a first domain and a covalently crosslinkable transglutaminase substrate domain in a second domain,   iii) providing a third component comprising the fusion peptide,   wherein the third component does not contain fibrinogen, a fibrinogen precursor thrombin, nor a thrombin precursor,   iv) mixing the first and third components to form a mixture of the first and third components, and   v) adding the second component to the mixture of step (iv) within 5 days after mixing the first and third components.   
     
     
         2 . The method of  claim 1 , wherein the fusion peptide comprises parathyroid hormone (PTH) in the first domain. 
     
     
         3 . The method of  claim 2 , wherein PTH is selected from the group consisting of PTH1-84, PTH1-38, PTH1-34, PTH1-31, and PTH1-25. 
     
     
         4 . The method of  claim 1 , wherein the first component or the second component further comprises a calcium ion source. 
     
     
         5 . The method of  claim 1 , wherein in step (iv), the fusion peptide is added in a concentration range of 0.01 to 2 mg/mL fibrin matrix. 
     
     
         6 . The method of  claim 1 , wherein the first component comprises a transglutaminase precursor and wherein the transglutaminase precursor is Factor XIII. 
     
     
         7 . The method of  claim 1 , wherein the fusion peptide further comprises a degradation site between the first and second domains. 
     
     
         8 . The method of  claim 7 , wherein the degradation site is an enzymatic cleavage site. 
     
     
         9 . The method of  claim 8 , wherein the enzymatic cleavage site is a plasmin cleavage site. 
     
     
         10 . The method of  claim 1 , wherein the method is performed under sterile conditions. 
     
     
         11 . The method of  claim 1 , further comprising (vi) administering the mixture of step (v) to a patient at a site in need of bone generation, of a bone cyst, or of a bone fracture. 
     
     
         12 . The method of  claim 11 , wherein the site in need of bone generation is a bone in a state of low bone density. 
     
     
         13 . The method of  claim 11 , wherein the site in need of bone generation is in the spine and the patient is undergoing a spinal fusion. 
     
     
         14 - 19 . (canceled) 
     
     
         20 . The method of  claim 11 , wherein step (vi) occurs within 5 days of initiating step (iv). 
     
     
         21 . The method of  claim 1 , wherein less than 7.8% of the fusion peptide degrades during step (v). 
     
     
         22 . The method of  claim 1 , wherein less than 4.3% of the fusion peptide degrades during step (v). 
     
     
         23 . The method of  claim 1 , wherein step (v) occurs during step (iv). 
     
     
         24 . The method of  claim 1 , wherein the first component is provided in a first container or compartment, wherein the second component is provided in a second container or compartment, and wherein the third component is provided in a third container or compartment,
 wherein during steps (iv) and (v) the first, second, and third containers or compartments are attached directly or indirectly to a connecting device.   
     
     
         25 . The method of  claim 24 , wherein the connecting device comprises a static mixer.